Objective
The T1D Collaborative is a group of companies, nonprofits and academic researchers organized to focus on rapidly delivering life changing therapeutics to people living with, or at risk of developing, Type One Diabetes, (“Collaborative”). Convergency brings these groups together to educate global regulators, health care providers and others that directly impact approval of and access to the most effective and advanced T1D therapies, the highest quality of care, and the most optimal outcomes.
Background Rationale
The T1D Collaborative is a group of companies, nonprofits and academic researchers organized to focus on rapidly delivering life changing therapeutics to people living with, or at risk of developing, Type One Diabetes, (“Collaborative”). Convergency brings these groups together to educate global regulators, health care providers and others that directly impact approval of and access to the most effective and advanced T1D therapies, the highest quality of care, and the most optimal outcomes.
Description of Project
The T1D Collaborative is a group of companies, nonprofits and academic researchers organized to focus on rapidly delivering life changing therapeutics to people living with, or at risk of developing, Type One Diabetes, (“Collaborative”). Convergency brings these groups together to educate global regulators, health care providers and others that directly impact approval of and access to the most effective and advanced T1D therapies, the highest quality of care, and the most optimal outcomes.
Anticipated Outcome
The T1D Collaborative is a group of companies, nonprofits and academic researchers organized to focus on rapidly delivering life changing therapeutics to people living with, or at risk of developing, Type One Diabetes, (“Collaborative”). Convergency brings these groups together to educate global regulators, health care providers and others that directly impact approval of and access to the most effective and advanced T1D therapies, the highest quality of care, and the most optimal outcomes.
Relevance to T1D
The T1D Collaborative is a group of companies, nonprofits and academic researchers organized to focus on rapidly delivering life changing therapeutics to people living with, or at risk of developing, Type One Diabetes, (“Collaborative”). Convergency brings these groups together to educate global regulators, health care providers and others that directly impact approval of and access to the most effective and advanced T1D therapies, the highest quality of care, and the most optimal outcomes.